Mitoxantrone in secondarily progressive multiple sclerosis: a series of 18 patients Mitoxantrone na esclerose múltipla secundária progressiva relato de 18 casos

Mitoxantrone in secondarily progressive multiple sclerosis: a series of 18 patients Mitoxantrone na esclerose múltipla secundária progressiva relato de 18 casos

Mitoxantrone hydrochloride (Novantrone®) is an anthracenedione that has been used as one of the latest in a long line of general immunosuppresive agents studied in multiple sclerosis (MS). We reviewed the clinical, laboratory, neuroimaging and echocardiography data of 18 patients from February 2001...

Full description

Bibliographic Details
Main Authors:	María Belén Montú, Walter Oleschko Arruda, Marcelo de Souza R. de Oliveira, Ricardo Ramina
Format:	Article
Language:	English
Published:	Academia Brasileira de Neurologia (ABNEURO) 2005-06-01
Series:	Arquivos de Neuro-Psiquiatria
Subjects:	mitoxantrone esclerose múltipla doença desmielinizante multiple sclerosis demyelinating disease
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2005000200007

Similar Items

Acute myeloid leukaemia induced by mitoxantrone: case report Leucemia mielóide aguda induzida por mitoxantrone: relato de caso
by: Walter Oleschko Arruda, et al.
Published: (2005-06-01)

Mitoxantrone-induced neurotoxicity in CD-1 mice
by: Ana Dias-Carvalho, et al.
Published: (2022-04-01)

Modified Photochemical Properties of Mitoxantrone by Plasmonic Photothermal Response of Hollow Gold Nanoshells
by: Armin Imanparast, et al.
Published: (2019-01-01)

Combined percutaneous ethanol injection and mitoxantrone versus radiofrequency ablation in the treatment of hepatocellular carcinoma
by: Besher Helmy, et al.
Published: (2016-12-01)

Mitoxantrone-Induced Suicidal Erythrocyte Death
by: Markus Arnold, et al.
Published: (2014-11-01)

Mitoxantrone-Surfactant Interactions: A Physicochemical Overview
by: Mirela Enache, et al.
Published: (2016-10-01)

Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer
by: Johann de Bono, et al.
Published: (2016-03-01)

Reply to: Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer
by: Gianpaolo Perletti
Published: (2016-03-01)

The protection of the myocardium by amifostine against mitoxantrone-induced acute cardiotoxicity in rats
by: Vefki Gürhan Kadıköylü, et al.
Published: (2010-06-01)

The protection of the myocardium by amifostine against mitoxantrone-induced acute cardiotoxicity in rats
by: Vefki Gürhan Kadıköylü, et al.
Published: (2010-06-01)

Does physical exercise improve or deteriorate treatment of multiple sclerosis with mitoxantrone? Experimental autoimmune encephalomyelitis study in rats
by: Mohamed A. El-Emam, et al.
Published: (2022-03-01)

Mitoxantrone removal by electrochemical method: A comparison of homogenous and heterogenous catalytic reactions
by: Abbas Jafarizad, et al.
Published: (2017-08-01)

The impact of mitoxantrone on neurological disability in active multiple sclerosis patients
by: Mesaroš Šarlota, et al.
Published: (2004-01-01)

Use of Mitoxantrone in Early Secondary Progressive Multiple Sclerosis: An Observational Study of 48 Patients with Clinical and MRI Outcomes
by: Ahmet Kasım Kılıç, et al.
Published: (2009-06-01)

Evaluation of the PEG Density in the PEGylated Chitosan Nanoparticles as a Drug Carrier for Curcumin and Mitoxantrone
by: Yao Chen, et al.
Published: (2018-07-01)

Desafios no Diagnóstico e Tratamento da Esclerose Múltipla Pediátrica
by: Rita Lopes Silva
Published: (2016-08-01)

Binding mechanism of anti-cancer chemotherapeutic drug mitoxantrone to DNA characterized by magnetic tweezers
by: Dennis Kreft, et al.
Published: (2018-07-01)

Fraxetin Interacts Additively with Cisplatin and Mitoxantrone, Antagonistically with Docetaxel in Various Human Melanoma Cell Lines—An Isobolographic Analysis
by: Paula Wróblewska-Łuczka, et al.
Published: (2022-12-01)

Improved anticancer efficiency of Mitoxantrone by Curcumin loaded PLGA nanoparticles targeted with AS1411 aptamer
by: Maryam Hashemi, et al.
Published: (2021-01-01)

Combination therapy with mitoxantrone and plasma exchange in aggressive relapsing remitting multiple sclerosis: A preliminary clinical study
by: Nasim Tabrizi, et al.
Published: (2012-01-01)

Mitoxantrone in the treatment of multiple sclerosis: a single-center experience
by: Özlem Taşkapılıoğlu, et al.
Published: (2012-06-01)

Inflammation as a Possible Trigger for Mitoxantrone-Induced Cardiotoxicity: An In Vivo Study in Adult and Infant Mice
by: Ana Reis-Mendes, et al.
Published: (2021-05-01)

Ressonância magnética na esclerose múltipla: análise de 270 casos
by: Guilberto Minguetti
Published: (2001-09-01)

Mitoxantrone Quantification by HPLC-MS/MS in Caco-2 Culture Media
by: Yu. S. Tranova, et al.
Published: (2023-03-01)

Efficacy and toxicity of mitoxantrone and oral etoposide in the treatment of hormone-refractory prostate cancer: pilot study
by: Rafael Kaliks, et al.
Published: (2010-09-01)

Efficacy and toxicity of mitoxantrone and oral etoposide in the treatment of hormone-refractory prostate cancer: pilot study
by: Rafael Kaliks, et al.
Published: (2010-09-01)

The Increment of Genoprotective Effect of Melatonin due to “Autooptic” Effect versus the Genotoxicity of Mitoxantrone
by: M Zamani, et al.
Published: (2020-12-01)

Bortezomib potentiates antitumor activity of mitoxantrone through dampening Wnt/β-catenin signal pathway in prostate cancer cells
by: Ying Zhang, et al.
Published: (2021-10-01)

Reabilitação vestibular: utilidade clínica em pacientes com esclerose múltipla Vestibular rehabilitation: clinical benefits to patients with multiple sclerosis
by: Bianca Simone Zeigelboim, et al.
Published: (2010-01-01)

Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation
by: Harinder Gill, et al.
Published: (2020-05-01)

Esclerose múltipla: estudo de pacientes com a forma surto-remissão cadastrados na Secretaria de Estado da Saúde de Minas Gerais Multiple sclerosis: study of patients with relapsing-remitting form registered at Minas Gerais Secretary State for Health
by: Eustáquio Claret dos Santos, et al.
Published: (2007-09-01)

Alterações na Ressonância Magnética Preditoras da Conversão da Síndrome Clinicamente Isolada em Esclerose Múltipla
by: Sara Peixoto, et al.
Published: (2016-11-01)

A Precise Nanostructure of Folate-Overhung Mitoxantrone DNA Tetrahedron for Targeted Capture Leukemia
by: Ying-Zi Bu, et al.
Published: (2020-05-01)

Polymeric mixed micelles loaded mitoxantrone for overcoming multidrug resistance in breast cancer via photodynamic therapy
by: Li ZY, et al.
Published: (2017-09-01)

Mitoxantrone-preloaded water-responsive phospholipid-amorphous calcium carbonate hybrid nanoparticles for targeted and effective cancer therapy
by: Wang C, et al.
Published: (2019-02-01)

Co-Encapsulation of Mitoxantrone and β-Elemene in Solid Lipid Nanoparticles to Overcome Multidrug Resistance in Leukemia
by: Kambere Amerigos Daddy J.C., et al.
Published: (2020-02-01)

Vitamin E succinate-conjugated F68 micelles for mitoxantrone delivery in enhancing anticancer activity
by: Liu Y, et al.
Published: (2016-07-01)

Multiple sclerosis and herpesvirus interaction
by: Guilherme Sciascia do Olival, et al.
Published: (2013-09-01)

Tumor microenvironment-responsive micelles assembled from a prodrug of mitoxantrone and 1-methyl tryptophan for enhanced chemo-immunotherapy
by: Ru Wang, et al.
Published: (2023-12-01)

In vivo evaluation of Sono-chemo therapy via hollow gold nanoshells conjugated to mitoxantrone on breast cancer
by: Vahid Abolzadeh, et al.
Published: (2023-03-01)